🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 40637H109
- Market Cap
- Large Cap · $2 Billion
- Previous Symbol
- HTI
Business: Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. Their research targets the extracellular matrix, an area outside the cell that provides structural support in tissues and orchestrates many important biological activities, including cell migration, signaling and survival. Over many years, they have developed unique scientific expertise that allows them to pursue this target-rich environment for the development of future therapies.
Company Contact
- CEO
- Helen I. Torley
- CFO
- Laurie D. Stelzer
- Headquarters
- 11388 Sorrento Valley Road, San Diego, CA 92121
- Phone
- 858-794-8889
- Fax
- 858-704-8311
- Investor Relations
- Al Kildani · 858-704-8122 · ir@halozyme.com